Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Clinical Chemistry|June 18, 2024
Highly Sensitive Immunoassay for Long Forms of Cardiac Troponin T Using Upconversion LuminescenceSelma M Salonen, Tuulia J K Tuominen, Kirsti I S Raiko, et al.
The Journal of Physical Chemistry Letters|August 20, 2015
The Active Phase of Palladium during Methane OxidationA Hellman, A Resta, N M Martin, et al.
Cell Death and Differentiation|January 17, 2015
Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growthS Adi Harel, N Bossel Ben-Moshe, Y Aylon, et al.
Hormones and Behavior|March 1, 2026
Sex differences in corticotropin-releasing factor receptor-2α expressing neurons in acutely stressed miceJennifer J Lafrican, Katherine E Parra, Krystyna A Rybka, et al.
Frontiers in Immunology|February 6, 2026
Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccineKasey Stokdyk, Anusmita Sahoo, Sailaja Gangadhara, et al.
Bone Marrow Transplantation|September 12, 2007
The influence of palifermin (Kepivance) on oral mucositis and acute graft versus host disease in patients with hematological diseases undergoing hematopoietic stem cell transplantB Nasilowska-Adamska, P Rzepecki, J Manko, et al.
Acta Haematologica Polonica|July 1, 1981
[Treatment of acute leukemias in adults. IV. Treatment results on 375 patients at 9 hematology centers]D Apel, M Bielawiec, A Bodzenta, et al.
Iscience|July 1, 2026
In vitro recapitulation of intramuscular mRNA vaccination with naive and recall antigens using a human lymphoid follicle chip platformYunhao Zhai, Min Wen Ku, Ka Yang, et al.
Nature Biomedical Engineering|March 12, 2026
DNA origami vaccine nanoparticles improve humoral and cellular immune responses to infectious diseasesYang C Zeng, Olivia J Young, Qiancheng Xiong, et al.
The Lancet. Infectious Diseases|September 5, 2024
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trialFlonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, et al.
Pageof 8